We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Roche Diagnostics

Develops, manufactures, and markets a wide range of in vitro diagnostic systems, instruments, reagents, and tests read more Featured Products: More products

Download Mobile App





Roche Introduces Upcoming Cobas Pure and Cobas Pro Integrated Solutions at AACC Clinical Lab Expo

By LabMedica International staff writers
Posted on 28 Sep 2021

Roche Diagnostics (Basel, Switzerland) introduced the upcoming cobas Pure and cobas Pro integrated solutions at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo. More...

The global laboratory community came together for the event held at the Georgia World Congress Center in Atlanta, September 26-30.

Roche’s future offering of the cobas pure integrated solutions introduced at ACC 2021 is designed for the low-mid volume segment as a main analyzer in small independent labs or lab networks, dedicated analyzer for specific panels, STAT analyzer or back up analyzer. It is designed to provide fast turnaround time and simplified operations. The smart concept of self-operating maintenance executes tasks automatically in the background to support a reduction in the manual burden of daily maintenance. The new reagent carrier will require no operator preparation and will provide up to six months of onboard stability for chemistry and up to four months of onboard stability for immunoassay. The cobas pure integrated solution continues Hitachi’s legacy of reliable systems, which enables smooth workflows and fewer unplanned interruptions. The cobas pure integrated solutions is currently in development.

In addition, Roche introduced the cobas pro integrated solutions with new high throughput configurations to increase testing efficiency. This offering for medium-to-high-volume chemistry and immunoassay testing, features a modular design to offer labs greater flexibility to ramp up their testing capacity to adapt to evolving testing needs

Roche also highlighted the cobas 8100 automated workflow series that delivers automation without compromise through customized workflows. The cobas 8100 automated workflow series is a powerhouse that enables a flexible and fully automated workflow, allowing labs to optimize resources while simultaneously boosting output and quality of results. The cobas 8100 delivers short and predictable time to results across multiple disciplines. It features STAT sample prioritization, intelligent tube transport, upfront sample integrity checks, and an innovative automatic centrifuge module for faster cycle times. In addition to featuring a modular design, the workflow your way concept enables labs to choose workflows using primary, aliquot and mixed sample workflows.

Roche exhibited its cobas connection modules (CCM) featuring STAT prioritization and sample integrity checks, that deliver reliable results run after run. Its innovative design leverages dynamic workflows to reduce bottlenecks, decrease time to results and impact patient care. It offers high throughput transportation of up to 10,000 tests per hour and the flexibility to connect across multiple disciplines. Other products displayed at the event by Roche included the FDA-cleared high-sensitive Elecsys Troponin T Gen 5 STAT to aid in the diagnosis of myocardial infarction (MI). TnT Gen 5 enables clinicians to more quickly diagnose patients with suspected MIs, delivering industry leading turnaround time results in only nine minutes.

Related Links:
Roche Diagnostics 


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Portable Electronic Pipette
Mini 96
New
Automatic Chemiluminescence Immunoassay Analyzer
Shine i2000
New
8-Channel Pipette
SAPPHIRE 20–300 µL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








ADLM

Channels

Molecular Diagnostics

view channel
Image: Over 100 new epigenetic biomarkers may help predict cardiovascular disease risk (Photo courtesy of 123RF)

Routine Blood Draws Could Detect Epigenetic Biomarkers for Predicting Cardiovascular Disease Risk

Cardiovascular disease is a leading cause of death worldwide, yet predicting individual risk remains a persistent challenge. Traditional risk factors, while useful, do not fully capture biological changes... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The VENTANA HER2 (4B5) test is now CE-IVDR approved (Photo courtesy of Roche)

Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients

Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more

Pathology

view channel
Image: An adult fibrosarcoma case report has shown the importance of early diagnosis and targeted therapy (Photo courtesy of Sultana and Sailaja/Oncoscience)

Accurate Pathological Analysis Improves Treatment Outcomes for Adult Fibrosarcoma

Adult fibrosarcoma is a rare and highly aggressive malignancy that develops in connective tissue and often affects the limbs, trunk, or head and neck region. Diagnosis is complex because tumors can mimic... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.